Table 1.
Females | Males | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
E2 Dose response | PPTa | DPNb | E2/BSAc | G1d | E2 Dose response | PPT | DPN | E2/BSA | G1 | |
100 nM Compared to 10 nM β-E2 | 100 nM Compared to 10 nM β-E2 | |||||||||
GSe | NSo | NS | NS | |||||||
pGSf | NS | NS | NS | NS | ||||||
GPg | NS | NS | ||||||||
ERαj | NS | NS | NS | NS | NS | NS | NS | |||
ERβk | NS | NS | NS | |||||||
GPERl | NS | NS | NS | NS | NS | NS | ||||
AMPKh | NS | NS | NS | NS | NS | NS | NS | NS | ||
pAMPKi | NS | NS | ||||||||
CAMKKβm | NS | NS | NS | NS | NS | |||||
PP1n | NS | NS | NS | NS |
estrogen receptor-alpha (ERα) agonist propylpyrazole triol
estrogen receptor-beta (ERβ) agonist diarylpropionitrile (DPN)
estradiol-bovine serum albumin conjugate
transmembrane G protein-couple estrogen receptor (GPR30) agonist
glycogen synthase
phospho-GS
glycogen phosphorylase
5’-AMP-activated protein kinase
phospho-AMPK
estrogen receptor-alpha
estrogen receptor-beta
G protein-coupled estrogen receptor 1
calcium/calmodulin-dependent protein kinase kinase-beta
protein phosphatase-1
not significant